Best Seller Brilliant Violet 711™ Anti-human Cd2 30% Off - Today Only [C7chpB6x]

Brilliant Violet 711™ Anti-Human CD2

Discover the power of the Brilliant Violet 711™ conjugate with our anti-human CD2 antibody. This innovative reagent is designed to enhance your flow cytometry experiments with its exceptional brightness and compatibility. With the ability to detect low-level targets and maintain excellent resolution, our antibody is a game-changer for researchers in immunology and cellular biology.

• High brightness: The BV711 dye provides excellent fluorescence for detection.
• Long-wavelength excitation: Enables the use of violet lasers without compromising detection.

Product Details

Our Best Seller Brilliant Violet 711™ Anti-human Cd2 30% Off - Today Only [C7chpB6x] antibody, clone RPA-2.10, is a monoclonal antibody with high specificity for human CD2. This glycoprotein, also known as LFA-2, T11, and sheep red blood cell receptor (SRBC-R), is expressed on various immune cells including thymocytes, T lymphocytes, NK cells, and thymic B cell subsets. The antibody recognizes both human and non-human primate cells, making it versatile for a wide range of applications. Key specifications include:

• Antibody Type: Monoclonal
• Reactivity: Human, Cynomolgus, Rhesus
• Format: BV711
• Host: Mouse
• Isotype: IgG1, κ

Applications and Benefits

The Best Seller Brilliant Violet 711™ Anti-human Cd2 30% Off - Today Only [C7chpB6x] antibody is ideal for flow cytometry, providing robust staining for your cellular analysis. Its exceptional brightness allows for clear visualization and precise quantification of CD2-expressing cells. Whether you are studying T cell activation, signaling pathways, or cell-cell adhesion, this antibody is a valuable tool in your research arsenal. Benefits include:

• Enhanced Detection: The BV711 dye enables detection of low-level targets.
• Multi-color Compatibility: Compatible with violet lasers, allowing for a broader range of experiments.

This antibody is suitable for researchers in academia and industry looking to advance their studies in immunology and cellular biology.